FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/096907 [Registered on: 04/11/2025] Trial Registered Prospectively
Last Modified On: 06/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Screening 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of two ayurvedic herbal tablets afsanteen and meethi seeds for pain relief during menstrution.  
Scientific Title of Study   Evaluation of Comparative Efficacy of Afsanteen (Artemisia absinthium Linn. ) Ghana vati verses Methika beej (Trigonella foenum-graecum Linn.) Ghana vati in management of kashtartava (Primary dysmenorrhea) -RCT 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mrunal Gawande 
Designation  BAMS post graduate 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Centre 
Address  First floor,room no 3,department of dravyaguna,Mahatma Gandhi Ayurved College Hospital and Research Centre,Salod(H),Wardha ,442001

Wardha
MAHARASHTRA
442001
India 
Phone  9112807879  
Fax    
Email  mrunalgawande55@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sneha Vidhate 
Designation  Assosiate professor,department of dravyaguna 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Centre 
Address  First floor,room no 3,department of dravyaguna,Mahatma Gandhi Ayurved College Hospital and Research Centre,Salod(H),Wardha ,442001

Wardha
MAHARASHTRA
442001
India 
Phone  8552838670  
Fax    
Email  sneha.vidhate@dmiher.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Mrunal Gawande 
Designation  BAMS post graduate 
Affiliation  Mahatma Gandhi Ayurved College Hospital and Research Centre 
Address  First floor,room no 3,department of dravyaguna,Mahatma Gandhi Ayurved College Hospital and Research Centre,Salod(H),Wardha ,442001

Wardha
MAHARASHTRA
442001
India 
Phone  9112807879  
Fax    
Email  mrunalgawande55@gmail.com  
 
Source of Monetary or Material Support  
MGACHRC 
 
Primary Sponsor  
Name  MGACHRC 
Address  Mahatma gandhi ayurved college hospital and research centre,salod,wardha 442001 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR Mrunal Gawande  MGACHRC  Mahatma Gandhi Ayurved college hospital and research centre,salod,wardha ,442001
Wardha
MAHARASHTRA 
9112807879

mrunalgawande55@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee,MGACHRC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Primary Dysmenorrhea 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Afsanteen, Reference: Commentary of Pandey & Chunekar on Bhavprakash Nighantu, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -warm water), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Methika beej, Reference: Arka Prakashan by Tripathi, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -warm water), Additional Information: -
 
Inclusion Criteria  
Age From  11.00 Year(s)
Age To  18.00 Year(s)
Gender  Female 
Details  Patients with sign and symptoms of primary dysmenorrhea like pain in lower abdomen radiating toward back and legs with associated symptoms like nausea ,headache ,fatigue . 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction in intensity of pain in primary dysmenorrhea  3 months 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size
Modification(s)  
Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   12/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Primary dysmenorrhea Kashtartava is a prevalent gynecological disorder affecting adolescent girls, causing significant discomfort and reduced quality of life. Conventional NSAIDs provide relief but are often associated with adverse effects, highlighting the need for safer alternatives. This randomized controlled clinical trial evaluates the comparative efficacy of Afsanteen Artemisia absinthium Linn. Ghana vati and Methika beej Trigonella foenum-graecum Linn.Ghana vati in managing Kashtartava. Fifty participants aged 11 to18 years were randomized into two groups and treated for three consecutive cycles. Outcomes were assessed using VAS and VMS scales. The study aims to provide evidence-based validation of Ayurvedic interventions for primary dysmenorrhea. 
Close